कृपया अन्य खोज का प्रयास करें
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Sean Stalfort | 52 | 2018 | Independent Chairman of the Board |
Jeffrey L. C. Ives | 71 | 2014 | Independent Director |
Kimberlee Cobleigh Drapkin | 54 | 2022 | Independent Director |
Laura Stoppel | 36 | 2020 | Independent Director |
Nathan B. Fountain | 60 | 2021 | Independent Director |
Jeffrey L. Cummings | 73 | - | Member of Clinical & Scientific Advisory Board |
Reisa Sperling | - | - | Member of Clinical & Scientific Advisory Board |
Stephen Salloway | - | - | Member of Clinical & Scientific Advisory Board |
Cynthia A. Lemere | - | - | Member of Clinical & Scientific Advisory Board |
Colin Louis Masters | 76 | - | Member of Clinical & Scientific Advisory Board |
Derrell D. Porter | 52 | 2023 | Independent Director |
Lennart Mucke | - | 2022 | Member of the Scientific Advisory Board |
Michael A. Weiner | 76 | - | Member of Clinical & Scientific Advisory Board |
Steven T. DeKosky | - | - | Member of Clinical & Scientific Advisory Board |
Daniel J. O'Connell | 53 | 2006 | CEO & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है